BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 14988745)

  • 1. Metastatic renal cell cancer treatments.
    Sternberg CN
    Drugs Today (Barc); 2003; 39 Suppl C():39-59. PubMed ID: 14988745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metastatic clear cell renal cell carcinoma: A review of current therapies and novel immunotherapies.
    Thomas JS; Kabbinavar F
    Crit Rev Oncol Hematol; 2015 Dec; 96(3):527-33. PubMed ID: 26299335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of cytokine therapy in 2006 and beyond for metastatic renal cell cancer.
    Parton M; Gore M; Eisen T
    J Clin Oncol; 2006 Dec; 24(35):5584-92. PubMed ID: 17158544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal cell carcinoma: novel treatments for advanced disease.
    Huland E; Heinzer H
    Curr Opin Urol; 2003 Nov; 13(6):451-6. PubMed ID: 14560137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy for renal cell carcinoma.
    Rosenblatt J; McDermott DF
    Hematol Oncol Clin North Am; 2011 Aug; 25(4):793-812. PubMed ID: 21763968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy of metastatic renal cell cancer.
    Fishman M; Seigne J
    Cancer Control; 2002; 9(4):293-304. PubMed ID: 12228755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New therapeutic developments in renal cell cancer.
    Prenen H; Gil T; Awada A
    Crit Rev Oncol Hematol; 2009 Jan; 69(1):56-63. PubMed ID: 18752971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy of metastatic renal cell carcinoma.
    McDermott DF; Atkins MB
    Cancer J; 2008; 14(5):320-4. PubMed ID: 18836337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcome of combined immunotherapy with interferon-alpha and low-dose interleukine-2 for Japanese patients with metastatic renal cell carcinoma.
    Miyake H; Kurahashi T; Takenaka A; Inoue TA; Fujisawa M
    Urol Oncol; 2009; 27(6):598-603. PubMed ID: 18818106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel immunotherapeutic strategies in development for renal cell carcinoma.
    Inman BA; Harrison MR; George DJ
    Eur Urol; 2013 May; 63(5):881-9. PubMed ID: 23084331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy in renal cell carcinoma.
    Bukowski RM
    Oncology (Williston Park); 1999 Jun; 13(6):801-10; discussion 810, 813. PubMed ID: 10378218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy for renal cell cancer.
    Yang JC; Childs R
    J Clin Oncol; 2006 Dec; 24(35):5576-83. PubMed ID: 17158543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy and targeted therapies in metastatic renal cell carcinoma: is there a preferred sequence?
    Giuliani J; Drudi F
    Cancer Biother Radiopharm; 2012 Oct; 27(8):513-8. PubMed ID: 22738404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapeutic strategies in kidney cancer--when TKIs are not enough.
    Biswas S; Eisen T
    Nat Rev Clin Oncol; 2009 Aug; 6(8):478-87. PubMed ID: 19546865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy for metastatic renal cell carcinoma: is it a therapeutic option yet?
    Guida M; Colucci G
    Ann Oncol; 2007 Jun; 18 Suppl 6():vi149-52. PubMed ID: 17591810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune therapy for kidney cancer: a second dawn?
    McDermott DF; Atkins MB
    Semin Oncol; 2013 Aug; 40(4):492-8. PubMed ID: 23972713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunotherapy of metastatic renal cell cancer].
    Manseck A; Wirth M
    Urologe A; 1993 Sep; 32(5):360-73. PubMed ID: 7692655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can vaccination or tyrosine kinase inhibitor therapy play a role in the adjuvant treatment of renal cell carcinoma?
    Brookman-May S; May M; Gilfrich C; Wieland WF; Burger M
    Expert Rev Anticancer Ther; 2010 Jun; 10(6):813-23. PubMed ID: 20553207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy for renal cell carcinoma.
    Belldegrun A; Figlin R; Danella J; deKernion J
    Semin Urol; 1992 Feb; 10(1):23-7. PubMed ID: 1565900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral blood neutrophils as independent immunologic predictor of response and long-term survival upon immunotherapy in metastatic renal-cell carcinoma.
    Atzpodien J; Reitz M
    Cancer Biother Radiopharm; 2008 Feb; 23(1):129-34. PubMed ID: 18298337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.